Thalamic inputs to dorsomedial striatum are involved in inhibitory control: evidence from the five-choice serial reaction time task in rats by Saund, Jasjot et al.
Open Research Online
The Open University’s repository of research publications
and other research outputs
Thalamic inputs to dorsomedial striatum are involved
in inhibitory control: evidence from the five-choice
serial reaction time task in rats
Journal Item
How to cite:
Saund, Jasjot; Dautan, Daniel; Rostron, Claire; Urcelay, Gonzalo P. and Gerdjikov, Todor V. (2017). Thalamic inputs
to dorsomedial striatum are involved in inhibitory control: evidence from the five-choice serial reaction time task in
rats. Psychopharmacology, 234(16) pp. 2399–2407.
For guidance on citations see FAQs.
c© 2017 The Authors
Version: Version of Record
Link(s) to article on publisher’s website:
http://dx.doi.org/doi:10.1007/s00213-017-4627-4
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
ORIGINAL INVESTIGATION
Thalamic inputs to dorsomedial striatum are involved
in inhibitory control: evidence from the five-choice serial reaction
time task in rats
Jasjot Saund1 & Daniel Dautan2 & Claire Rostron3 & Gonzalo P. Urcelay1 &
Todor V. Gerdjikov1
Received: 28 July 2016 /Accepted: 7 April 2017 /Published online: 28 April 2017
# The Author(s) 2017. This article is an open access publication
Abstract
Rationale Corticostriatal circuits are widely implicated in the
top-down control of attention including inhibitory control and
behavioural flexibility. However, recent neurophysiological
evidence also suggests a role for thalamic inputs to striatum
in behaviours related to salient, reward-paired cues.
Objectives Here, we used designer receptors exclusively acti-
vated by designer drugs (DREADDs) to investigate the role of
parafascicular (Pf) thalamic inputs to the dorsomedial striatum
(DMS) using the five-choice serial reaction time task
(5CSRTT) in rats.
Methods The 5CSRTT requires sustained attention in order to
detect spatially and temporally distributed visual cues and
provides measures of inhibitory control related to impulsivity
(premature responses) and compulsivity (perseverative re-
sponses). Rats underwent bilateral Pf injections of the
DREADD vector, AAV2-CaMKIIa-HA-hM4D(Gi)-IRES-
mCitrine. The DREADD agonist, clozapine N-oxide (CNO;
1 μl bilateral; 3 μM) or vehicle, was injected into DMS 1 h
before behavioural testing. Task parameters were manipulated
to increase attention load or reduce stimulus predictability
respectively.
Results We found that inhibition of the Pf-DMS projection
significantly increased perseverative responses when stimulus
predictability was reduced but had no effect on premature
responses or response accuracy, even under increased atten-
tional load. Control experiments showed no effects on loco-
motor activity in an open field.
Conclusions These results complement previous lesion work
in which the DMS and orbitofrontal cortex were similarly
implicated in perseverative responses and suggest a specific
role for thalamostriatal inputs in inhibitory control.
Keywords Thalamostriatal pathway . Dorsomedial striatum .
Parafascicular thalamic nucleus . 5-choice serial reaction time
task
Introduction
Adapting to changing environments requires the allocation of
attentional resources including inhibition of inappropriate
responding to allow efficient goal-directed behaviour. These
functions have traditionally been associated with the
corticostriatal network; however, emerging evidence suggests
that corticostriatal inputs are subject to thalamic modulation in
the striatum (Bradfield et al. 2013a, b).
In rodents, excitotoxic lesions of the dorsomedial striatum
(DMS) produce deficits in inhibitory control measured in the
five-choice serial reaction time task (5CSRTT), which allows
the assessment of both attentional and inhibitory control
(Robbins 2002). DMS lesions increase premature and persev-
erative responding, reflecting deficits in impulsivity and com-
pulsivity, respectively (Rogers et al. 2001). In line with these
inhibitory deficits, lesions of the orbitofrontal cortex (OFC)
(Chudasama et al. 2003), an area which projects to the DMS in
a topographic manner (Schilman et al. 2008), increase persev-
erative responses in the 5CSRTT. This parallels the effects of
OFC and DMS lesions in reversal learning tasks, which also
result in an increase in perseverative responses after
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contingency reversal (Boulougouris et al. 2007; Castañé et al.
2010; Ragozzino et al. 2002).
In addition to receiving inputs from the OFC (Schilman
et al. 2008), the DMS is also a target for thalamic inputs
(Groenewegen and Berendse 1994), primarily from
intralaminar thalamic nuclei (ILN), composed of the
centromedian (CM) and parafascicular (Pf) nuclei. Primate
studies suggest the CM-Pf complexmay provide striatumwith
behaviourally relevant information (Kimura et al. 2004;
Matsumoto et al. 2001; Minamimoto and Kimura 2002); this
is supported by imaging studies in humans showing activation
of the ILN during an attention-demanding task (Kinomura
et al. 1996). Rat lesion studies also implicate Pf in behavioural
flexibility. Thus, similar to the deficits observedwith OFC and
DMS lesions in reversal learning, Pf lesions also impair T-
maze reversal learning (Brown et al. 2010) and lead to in-
creased lever pressing after contingency degradation of an
instrumental response (Bradfield et al. 2013a). These studies
suggest a possible role of the Pf in modulating striatal activity
when performance is assessed under changing conditions.
However, the specific contribution of this circuit to attentional
and inhibitory control has not been isolated experimentally. To
address this, here, we characterised the effect of chemogenetic
inhibition of the Pf-DMS pathway in the 5CSRTT under task
conditions where either stimulus predictability was degraded
or attentional load was increased. Stimulus unpredictability
has previously been shown to decrease inhibitory control
(Chudasama et al. 2003). Inhibition of the Pf-DMS pathway
was achieved by use of designer receptors exclusively activat-
ed by designer drugs (DREADDs). DREADDs are G protein-
coupled receptors that are only activated by their otherwise
inert ligand, clozapine N-oxide (CNO), which shows high
receptor specificity (Alexander et al. 2009; Armbruster et al.
2007; Wess et al. 2013). Here, the use of a Gi-coupled
DREADD allowed the inhibition of Pf-DMS projections
which is thought to be due to synaptic silencing (Alexander
et al. 2009; Armbruster et al. 2007). We found that inhibition
of this projection significantly increased perseverative re-
sponses (a failure of inhibitory control linked to compulsivity)
when stimulus predictability was reduced but had no effect on
accuracy, even under increased attentional load.
Methods
Animals
Ten male Long Evans adult rats, bred within the University of
Leicester Central Research Facility, were housed in groups of
two or three in a reverse lit room (lights on between 7 pm and
7 am) with constant temperature (22 °C) and humidity (50%).
Ad libitum food was restricted to 1–2 h/day on weekdays and
was freely available on weekends. Weights were monitored
and remained at ∼90% of free-feeding weight. Behavioural
testing was carried on weekdays during the dark phase. All
experimental and surgical procedures were done in compli-
ance with the Animals (Scientific procedures) Act 1986, UK.
Apparatus
Training was carried out in four operant chambers [Med
Associates, Fairfield, VT; 30 × 31 × 24 cm (height × width
× depth); prod. no. ENV-008] placed in sound-attenuated,
ventilated cubicles. One side of the chambers comprised the
five-choice panel, curved concavely with five apertures with
stimulus lights at the back (prod. no. ENV-115A-07V). The
other side contained a recessed food magazine, a magazine
light and a house light. Entries into all apertures including
the food magazine were monitored by a photocell infrared
beam. A data acquisition board (National Instruments PCI-
6229) interfaced with the operant chambers and custom-
written software were used for experimental control and be-
havioural data acquisition (Labview, National Instruments,
Austin, TX, USA). Dustless precision pellets were used as
rewards (45 mg, Product No F0021, Bioserv Dustless
Precision Pellets, Frenchtown NJ).
Procedure
Behavioural paradigm
The 5CSRTT, as previously described by Robbins (2002),
involves the presentation of a visual stimulus in one of five
apertures. Rats were required to attend to these apertures and
respond with a nose poke into the aperture in which the stim-
ulus was presented. Each session, lasting 40 min or 100 trials
(whichever occurred first), began with the delivery of a reward
pellet and the illumination of the house light and the magazine
light. To initiate the trial, the rat was required to nose-poke
into the magazine, after which the magazine light was
extinguished, and the inter-trial interval (ITI) began. After
the ITI, the light stimulus was illuminated in a random aper-
ture on the five-choice panel. A correct response was recorded
if the rat nose-poked into the illuminated aperture within a set
time (the limited hold). This triggered the illumination of the
magazine light and the release of a sugar pellet from the mag-
azine. A response into the wrong aperture (an incorrect re-
sponse), a response during the ITI (a premature response) or
no response within the limited hold (an omission) were
punished with a 5-s timeout in which all lights including the
house light were turned off.
Initial training was carried out with longer stimulus dura-
tions and limited holds and shorter ITIs which were gradually
adjusted based on individual performances to reach target pa-
rameters which were stimulus duration (SD), 1.5 s; limited
hold (LH), 5 s; ITI, 5 s and timeout 5 s. Virus injection and
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cannula implantation were carried out once animals achieved
80% accuracy (% correct responses out of total number of
responses).
Two weeks following surgery, rats were retrained to crite-
rion and tested on two challenges in the paradigm. The atten-
tional challenge consisted of presenting trials with shorter SDs
(1 vs. 2 s, presented randomly within session; initial pre-
training had used an SD of 1.5 s) in order to increase atten-
tional load. LH and ITI were fixed at 5 s. A second challenge
to test inhibitory control consisted of a varied ITI duration
within each session to reduce stimulus predictability
(Chudasama et al. 2003). The ITIs were: 4.5, 6, 7.5 and 9 s
as used previously (Chudasama et al. 2003). LH was fixed at
5 s and SD at 1.5 s. For each challenge, animals were tested
over four consecutive days alternating between vehicle and
drug injection days (two of each in total). CNO or vehicle
was injected 1 h prior to testing sessions (see ‘Central
Infusions’) (Aldrin-Kirk et al. 2016).
Performance measures
Accuracy was expressed as the percentage of correct re-
sponses (%correct trials/attempted trials). Omissions were
calculated as the percentage of omitted trials out of the
total number of trials. Premature and perseverative re-
sponses were used as measures of inhibitory control.
Premature responses were counted as responses made dur-
ing the ITI and calculated as a percentage out of all trials.
Perseverative responses were defined as nose-pokes into
one of the five apertures after a correct response was
made but before collection of the reward as has been
reported previously (Chudasama et al. 2003) and
expressed as a percentage out of the number of correct
trials. Response latencies were calculated as the time tak-
en to respond to a stimulus on correct trials. Latency to
collect reward was taken as the time between reward de-
livery and collection of the reward.
Surgical procedures
DREADD injection
Rats were anaesthetised with 4% v/v isoflurane (Schering-
Plough) in O2 and maintained between 2 and 3%. The animal
was mounted in a stereotaxic frame, and the headwas adjusted
so that lambda and bregma were aligned on the same horizon-
tal plane. To prevent corneal desiccation, Lacri-Lube Eye
Ointment (Allergan, Westport, Ireland) was applied to the
eyes. A homoeothermic heat pad (Harvard Apparatus,
Boston, Massachusetts, USA) was used tomaintain body tem-
perature between 36 and 37 °C. Glucose (5%, 3 ml/h, s.c.) was
given via an infusion pump (Intec, K.D, Scientific, Holliston,
Massachusetts, USA) for the duration of the surgery. Small
craniotomies were made directly above the virus injection
sites; Pf target coordinates were −4.2 mm AP, ±1.8 mm ML
and −5.5 mm DV (Paxinos and Watson 2005). Dorsal ventral
coordinates were taken from the dura; all other coordinates
were from bregma.
A 1-μl Hamilton syringe (Neuros 7000 Series) was
mounted on an infusion pump (Pump 11 Elite Nanomite,
Harvard Apparatus, Holliston, MA,USA) and filled with
0.8 μl of virus, AAV2-CaMKIIa-HA-hM4D(Gi)-IRES-
mCitrine (University of North Carolina – Vector Core).
The virus was injected at a rate of 50 nl/min into Pf,
and the injection needle was left in place for a further
10 min to allow diffusion. This injection was done bilat-
erally with the syringe cleaned and reloaded with virus
between injections (Fig. 1a).
Cannula implantation
Cannula guides were implanted in DMS to allow the cen-
tral injections of the DREADD agonist, CNO. These were
done in the same surgery as the virus injections.
Coordinates used for DMS were −0.5 mm AP, ±1.8 mm
ML and −3.0 mm DV (Paxinos and Watson 2005). Dorsal
ventral coordinates were taken from the dura; all other
coordinates were from bregma.
Custom-made 23-gauge cannulas were inserted bilaterally
into the striatal coordinates and fixed in place using light-
curing dental cement (Flowable Composite, Henry Schein;
Gillingham, UK). Stainless steel stylets were placed in the
cannulas to prevent blockage.
Post-operative care
A non-steroidal anti-inflammatory (Carprieve, 5 mg/kg; S.C.;
Norbrook Laboratories Ltd.; Corby, UK) was administered
1–2 h before recovery and twice a day for 5 days post-surgery.
An antibiotic (Baytril, 2.5%, 0.2 ml/kg; S.C.; Bayer;
Leverkusen, Germany) was given immediately after recovery
and twice daily for 5 days after surgery.
Central infusions
One hour prior to testing, 1 μl of 3 μM CNO or vehicle
(artificial CSF + DMSO) was injected through the DMS can-
nula guides using a 10-μl Hamilton precision syringe connect-
ed to polyethylene tubing with a 30-gauge steel injector on the
end. The injector protruded beyond the cannula length by
1 mm. CNO was injected at a rate of 0.5 μl/min, and the
injector was left in place for another minute to allow for drug
diffusion. The CNO dose used here was similar to published
work (Stachniak et al. 2014). The drug was injected 1 h prior
to testing following work from the Roth lab showing that
behavioural effects of CNO administration increase gradually,
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are robust after an hour and persist for many hours after ad-
ministration (Alexander et al. 2009).
Locomotion activity
Locomotor activity was assessed in an open-top black
Plexiglas box (52 wide × 52 long × 40 high) using a digital
camera and the ANY-MAZE tracking software (Stoelting, IL,
USA). Each session consisted of 40 min, and all animals com-
pleted two sessions (CNO vs vehicle, counterbalanced) on
two separate days. One hour prior to testing, the animals were
injected with 1 μl of either CNO or artificial CSF.
Histology
DREADD expression in Pf cell bodies and axon terminals in
the DMS was verified using labelling with green fluorescent
protein. Rats were terminally anaesthetised with pentobarbital
(250 mg/kg; IP) and perfused with 5% formaldehyde. Brains
were extracted and kept in saline for 2 days at 4 °C and sub-
sequently transferred to 0.05% sodium azide (w/v in saline)
and kept at 4 °C until sectioning. Coronal sections of the
striatum and the thalamus were cut at 50-μm thickness using
a vibratome (VT1200S; Leica). Sections were incubated in a
blocking solution consisting of 10% normal donkey serum
(NDS) in PBS containing 1% Triton X-100 for a minimum
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Fig. 1 Surgical preparation and
immunohistochemical
verification of anatomical targets.
a Sagittal view of the rat brain
indicating sites of virus injection
(AAV2-CaMKIIa-HA-
hM4D(Gi)-IRES-mCitrine) in the
Pf and CNO in the DMS. b Left
panel shows diagram of coronal
view of the intralaminar thalamic
nuclei with green eclipses
indicating individual virus
diffusion areas. Right panel
shows confocal image of a
thalamic slice indicating midline
and intralaminar thalamic nuclei
with GFP indicating expression of
the DREADD (arrow). Inset
shows Pf in higher magnification.
c Left panel shows a coronal view
of striatum indicating individual
cannula tracks. Right panel shows
a confocal image of striatum with
injection tracks indicated. Inset
shows DMS in higher
magnification to show presence
of GFP indicating DREADD
expression in Pf-DMS axonal
processes (marked with arrows)
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of 1 h. Sections were then washed three times in PBS and
incubated with antibody against green florescent protein
(GFP, 1:1000, raised in rabbit, Invitrogen, A21311) in 1%
normal donkey serum (NDS), 0.03% Triton X-100 in PBS.
Sections were mounted in slices and protected with
Vectashield. Z-Stack fluorescent images were obtained with
a confocal microscope (LSM-510, Zeiss) using the 504-nm
filter for Alexa Fluor-488 at two different magnifications, ×4
(0.4 numerical aperture) and ×20 (1.2 numerical aperture), at
2048 × 2048 resolution and a digital camera (Hamamatsu
ORCA-ER digital Camera, Hamamatsu Photonics K.K.).
The brightness and contrast of the images were subsequently
adjusted in ImageJ. Virus diffusion area and injector tracks
were reported on a single projection slice.
Data analysis
Time stamps of all behavioural events in the 5CSRTT were
recorded using custom-made LabVIEW software, and behav-
ioural data were analysed using within-subject analysis of var-
iance (ANOVA) with drug (CNO vs. vehicle) and parameter
value (ITI or SD duration) as the within-subject variables.
Statistical analyses were performed using SPSS (IBM SPSS,
Somers, NY, USA). In several cases, drug treatment was crit-
ically found to have no effect on omissions or in locomotor
activity. In these cases, we computed Bayes factors for use in
supporting the null hypothesis using a freely available Bayes
factor calculator (http://pcl.missouri.edu/bayesfactor). In all
cases, the scale of r was set up to 1.0 which serves as a
natural benchmark (Rouder et al. 2009).
Results
Histology
Verification of DREADD expression was carried using green
fluorescent protein. Virus expression was detected in both Pf
cell bodies and DMS axon terminals. Verification of DMS
cannula implantation sites was also confirmed histologically
(Fig. 1b, c). Two animals with an off-target virus injection and
a DMS cannula site respectively were removed from subse-
quent analyses. Thus, the analyses reported below are based
on N = 8 rats undergoing repeated-measures testing.
Effect of CNO on 5CSRTT performance measures
Prior to testing, animals reached an average accuracy of
86.5 ± 1.5% (mean ± SEM) and an average of 20.0 ± 4.2%
omissions. CNO did not have an effect on the total number of
trials that the rats completed on the varied ITI or the shorter
SD challenges [F(1, 7) = 0.08, p = 0.788 and F(1, 7) = 0.25,
p = 0.617, respectively].
Variable ITI challenge
To determine the effect of CNO on response measures under
decreased stimulus predictability, we injected CNO or vehicle
on 2 days (2 CNO and 2 artificial CSF days, counterbalanced)
where ITI duration was varied within-session: 4.5, 6, 7.5 or
9 s. This experiment was analysed using a 4 × 2 × 2 (ITI
duration x drug x repetition) within-subjects ANOVA. The
variable repetition was added since two CNO and two vehicle
days were recorded. Due to a violation of the sphericity as-
sumption, the Greenhouse-Geisser correction was applied.
Reduced stimulus predictability affected response measures
as expected: we saw an increase in omissions [F(1.488,
10.413) = 9.97, p = 0.006] and an increase in premature
responding [F(3, 18) = 91.47, p < 0.001] (see Table 1).
These patterns replicate previous work (Chudasama et al.
2003).
CNO had no significant effect on accuracy [F(1, 7) = 0.32,
p = 0.590], omissions [F(1, 7) = 0.98, p = 0.356] or premature
responses [F(1, 7) = 0.98, p = 0.356] (Fig. 2a–c). A Bayesian
analysis conducted on omission trials found that these data are
2.53 times more likely to be observed under the null hypoth-
esis predicting no difference between CNO and vehicle.
However, CNO did increase significantly the percentage of
perseverative responses [F(1, 7) = 7.13, p = 0.032] (Fig. 2d)
without producing a drug × ITI interaction [F(3, 21) = 0.72,
p = 0.550]. CNO treatment did not affect response latency or
latency to collect rewards [F(1, 7) = 0.12, p = 0.743 and F(1,
7) = 1.44, p = 0.269, respectively] (Fig. 2e, f). There were no
CNO × ITI interactions on any of the performance measures.
Further, there were no effects of repetition or interactions in-
volving repetition.
Shorter SD challenge
A second experiment assessed the effect of CNO on perfor-
mance measures under increased attentional load using two
stimulus durations within-session (1 vs 2 s; initial training had
been carried out using a stimulus duration of 1.5 s). CNO or
vehicle was injected on 2 days (2 CNO and 2 vehicle days,
counterbalanced), and the experiment was analysed using a
2 × 2 × 2 (stimulus duration × drug × repetition) within-
subjects ANOVA. The variable repetition was added since
two CNO and two vehicle days were recorded.
As expected, accuracy was lower for 1 vs. 2 s stimuli
[mean ± SEM 87.8 ± 2.9% vs 89.6 ± 2.4%; F(1, 7) = 12.83,
p = 0.009], and percentage omissions were higher
[20.4 ± 2.7% vs 14.2% ± 1.9%, F(1, 7) = 28.94, p = 0.001].
Also, as expected response latencies were shorter for 1-s stim-
uli than for 2-s stimuli [0.88 ± 0.06 s vs 0.98 ± 0.06 s; F(1,
7) = 6.87, p = 0.034]. Stimulus duration did not affect persev-
erative responses [F(1, 7) = 0.90, p = 0.373].
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CNO did not appear to affect response parameters in this
challenge of the task: CNO had no significant effect on accu-
racy [F(1, 7) = 0.02, p = 0.869], percentage of omitted trials
[F(1, 7) = 0.02, p = 0.883], premature responses [F(1,
7) = 0.885, p = 0.378], perseverative responses [F(1,
7) = 0.05, p = 0.827], response latency [F(1, 7) = 0.28,
p = 0.612] or latency to collect rewards [F(1, 7) = 0.28,
p = 0.613]. There were no CNO × SD interactions on either
of the performance measures. A Bayesian analysis conducted
on omission trials found that these data are 3.87 times more
likely to be observed under the null hypothesis predicting no
difference between CNO and vehicle.
Finally, our analysis of perseverative responses followed
previous work on response inhibition (Chudasama et al.
2003; Rogers et al. 2001) and included nose-pokes into any
nose hole (i.e. indiscriminately). Additional analyses when
considering only nose-pokes in the rewarded nose hole pro-
duced no drug effects or interactions involving drug treatment
(ps > .25 for all effects, drug × ITI × repetition within-subjects
ANOVA for the variable ITI challenge). The same was true
when considering the shorter SD challenge (ps > .30), except
we note that the p value for the effect of drug in the latter
analysis was p = .08 [F(1, 7) = 4.20].
Locomotion activity
To test for non-specific locomotor effects of CNO injections in
DMS, we recorded activity in an open field after CNO vs.
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Fig. 2 Inhibiting Pf-DMS
projections with CNO injections
in dorsomedial striatum produce a
specific perseverance deficit
when stimulus predictability is
degraded by varying ITI duration.
No significant effects of CNO are
seen in response accuracy (a),
percentage omissions (b) or
premature responses (c). In
contrast, CNO injection increases
perseverative errors (d). Response
latency (e) or latency to collect
reward (f) is not affected.
*Significant difference from
vehicle, p < .05 (within-subject
ANOVA). Error bars indicate
SEM. Data is averaged across
ITIs and the two repetitions
Table 1 Performance measure
averages (mean ± SEM) for the
four ITI durations
Performance measures ITI(s)
4.5 6 7.5 9
% Accuracy 90.3 (±1.9) 89.2 (±1.9) 87.0 (±2.9) 85.3 (±2.9)
% Omissions* 14.0 (±1.9) 16.1 (±1.7) 16.7 (±1.9) 27.2 (±3.9)
% Premature* 3.9 (±1.6) 18.8 (±3.8) 32.8 (±4.6) 53.0 (±5.1)
% Perseverative 10.0 (±3.8) 12.3 (±3.7) 14.2 (±4.3) 11.2 (±4.4)
Response latency(s) 0.90 (±.05) 0.89 (±.07) 0.86 (±.06) 0.86 (±.06)
Latency to collect reward(s) 2.03 (±.20) 2.10 (±.23) 2.13 (±.21) 2.01 (±.20)
*Significant main effect of the respective measure (p < 0.05)
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vehic le in jec t ions adminis tered on 1 of 2 days
(counterbalanced). Distance travelled (m) was binned into
eight 5-min time windows. A 2 × 8 (drug × bin) within-
subject ANOVA revealed no significant effect of drug or drug
× bin interaction [F(1, 7) = 1.17, p = 0.314 and F(7,
49) = 1.17, p = 0.339, respectively]. A Bayesian analysis
found that these data are 2.34 times more likely to be observed
under the null hypothesis predicting no difference between
CNO and vehicle. As expected, locomotor activity showed
significant habituation over time [F(7, 49) = 49.41,
p < 0.001] (Fig. 3).
Discussion
The present study investigated the role of the Pf-DMS
pathway in inhibitor control and attention. We used
chemogenetic inhibition to temporarily and specifically
inactivate the Pf-DMS pathway and assessed performance
on behavioural measures in the 5CSRTT. Viral expression in
Pf cell bodies and processes in DMS was confirmed
immunohistochemically. Task parameters were systematically
manipulated to increase attentional load or reduce stimulus
predictability, respectively. The main finding of the study is
that inhibition of the Pf-DMS projection significantly in-
creases perseverative responses (a failure of inhibitory control
related to compulsivity) compared to vehicle when stimulus
predictability was reduced but had no effect on accuracy, even
under increased attentional load.
It is unlikely that non-specific effects of CNO injections
into DMS could explain the observed pattern of results.
Firstly, gross locomotor effects are unlikely because we did
not observe an effect on the total number of trials completed,
response latencies, reward retrieval latencies and ambulatory
activity in an open field. This conclusion was supported by
Bayesian analyses which suggested that the null hypothesis
(i.e. no effect) was more strongly supported by the data. While
our sample size was similar to previous reports of within-
subject pharmacological manipulations in the five-choice se-
rial reaction time task (Murphy et al. 2012; Pezze et al. 2007;
Robinson et al. 2008), the null findings on these additional
measures may require further investigation given that a priori
effect sizes are not available.
Further, with respect to the application of the DREADD
methodology, while one recent study reports retroconversion
of CNO to clozapine in rats and related behavioural effects
(MacLaren et al. 2016), we do not believe this is likely to
provide an alternative explanation for our specific findings:
multiple publications demonstrate that clozapine does not af-
fect perseverative responses in the 5-CSRTT with systemic
doses as high as 2.5 and 5 mg/kg (Baviera et al. 2008; Carli
et al. 2011; Turner et al. 2013). The absence of an effect on
perseverative responses is dissociable from an increase in
omissions reported in the latter two papers with doses of 2.5
and 5 mg/kg, respectively. The opposite pattern was observed
in our work: we saw an increase in perseverative responses but
no effect on omissions. Thus, it is unlikely that clozapine
mediates the behavioural effect seen here. Overall, non-
specific effects of CNO cannot explain the pattern of results
obtained in the current study.
Analysis of specific behavioural parameters as a function
of task manipulations confirmed the robustness of the proto-
col. As found previously, varying ITI duration increased both
premature responses and omissions (Chudasama et al. 2003).
Similarly, in the shorter SD challenge, the decrease in accura-
cy and higher number of omissions as well as decreased re-
sponse latency with shorter stimuli was not surprising and has
previously been reported (Amitai andMarkou 2011; Bari et al.
2008; Guillem et al. 2011).
In the current study, we found a specific role for the Pf-
DMS projection in perseverative responding. Perseverance on
the 5CSRTT is an indication of compulsivity (Dalley et al.
2011): compulsive behaviour is described as a repetitive inap-
propriate behaviour that persists, often despite negative out-
comes (Dalley et al. 2011). Perseverant behaviours can arise in
a variety of contexts including those requiring behavioural
flexibility and response inhibition. Here, perseverative entries
into the five apertures after a correct response are not only
unrewarded but are also disadvantageous in that they delay
the collection of the reward. This effect was specific to vari-
able ITI sessions but did not correlate with ITI length, sug-
gesting that it is driven by the temporal unpredictability of the
response cues. In contrast, DMS excitotoxic lesions produce
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Fig. 3 Local administration of CNO into dorsomedial striatum produces
no deficits in locomotor activity. Locomotion was measured as distance
travelled (mean ± SEM) in an open field after vehicle (artificial CSF) or
CNO administration recorded in 5-min bins. The inset shows distance
travelled (mean ± SEM) averaged for the whole 40-min session
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other deficits in addition to perseverative responses, including
premature responses and reduced accuracy, suggesting a more
general deficit related to both inhibitory and attentional con-
trol. DMS receives strong prefrontal innervation from OFC
(Schilman et al. 2008), and OFC-lesioned animals show in-
creased premature responses, omissions and perseverative re-
sponses. With extensive training, both the omission and pre-
mature deficits are reduced in OFC-lesioned rats, but the
perseverative deficits persist, suggesting a deficit parallel to
the one obtained using pharmacogenetic inhibition of the Pf-
DMS projection in the current study (Chudasama et al. 2003).
These observations further suggest that DMS integrates top-
down OFC and bottom-up Pf inputs, and disruption of either
of these produces perseverative behaviour.
The thalamostriatal behavioural deficit observed here
shows high specificity since other performance indices were
not affected by inhibiting the pathway in the varied ITI chal-
lenge, nor were any of performance measures affected in the
shorter SD challenge. This strengthens the suggestion that the
Pf-DMS pathway is specifically involved in behavioural flex-
ibility as opposed to attentional control. This is also consistent
with Pf lesion work which implicates this structure in behav-
ioural flexibility. For example, Pf-lesioned rats were unim-
paired when initially learning an action-outcome association
in a lever-pressing instrumental task and were sensitive to
outcome devaluation. However, when the contingencies
changed (i.e. were degraded), they were unable to update the
action-outcome association and thus failed to reduce
responding to the degraded lever (Bradfield et al. 2013a).
Furthermore, Pf inactivation also causes regressive errors in
T-maze reversal learning task (Brown et al. 2010). These re-
gressive errors reflect an inability to maintain the new action-
outcome contingency, further supporting the role of the Pf in
behavioural flexibility.
Additional support for the role of Pf in behavioural flexi-
bility arises from evidence implicating this structure in mod-
ulation of striatal cholinergic interneurons (CINs) (Brown
et al. 2010). Striatal CINs appear to mediate, to a large extent,
Pf inputs to the DMS. Not only are they shown to respond to
salient reward predicting stimuli (Doig et al. 2014;Matsumoto
et al. 2001), but this response is also shown to transiently
suppress the cortically driven medium spiny neurons
(MSNs). Furthermore, both DMS and Pf receive common
cholinergic projections from the cholinergic brainstem
(Dautan et al. 2014) that has also been showed to modulate
dopamine release in the striatum (Dautan et al. 2016a, b).
Whether and to what extent cholinergic and other intervening
interneuron and/or neuromodulator systems may mediate the
behavioural effects reported here should be investigated in
future studies [see also Faust et al. (2016)].
Finally, we have to acknowledge that the current study did
not specify the type of Pf cells targeted with CNO. Studies
suggest that Pf striatal projections are mainly glutamatergic
(Smith et al. 2014) and that glutamic acid decarboxylase
(GAD, the synthetic enzyme for GABA) immunoreactivity
in rat Pf is weak or absent (Bentivoglio et al. 1991).
However, the current data clearly does not contribute to this
discussion and these previous anatomical results may have to
be complemented with modern viral-based approaches.
Further, our observation of behavioural effects 1 h after intra-
cerebral CNO administration are in line with previous work
(Mahler et al. 2014; Stachniak et al. 2014). However, we have
to acknowledge the possibility that the time interval between
CNO administration and behavioural testing may potentially
affect the functioning of the transfected neurons independent-
ly or secondarily to the inhibition presumed here based on
previous work.
In summary, the present study examined the role of thalam-
ic input to the dorsomedial striatum in attention and behav-
ioural flexibility using the 5CSRTT. We manipulated task pa-
rameters to either increase attentional load or reduce stimulus
predictability to challenge behavioural flexibility; we
exploited the selectivity afforded by the DREADD approach
to specifically interrogate the contribution of the Pf-DMS
pathway to these processes and found that thalamic projec-
tions are implicated in perseverative responses, indicating a
role of this projection in inhibitory control. Our results suggest
that the behavioural role of dorsomedial striatummust be con-
sidered in the context of thalamostriatal projections in addition
to previously described prefrontal inputs.
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